Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Patients With Rapidly Progressive Interstitial Lung Disease
Clinical trial NCT02594839 · COMPLETED
Trial details
- NCT number
- NCT02594839
- Sponsor
- Federal Research Clinical Center of Federal Medical & Biological Agency, Russia
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-01
- Primary completion
- 2018-01-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.